Elbit Systems Ltd. secured a $435 million contract to supply advanced 30 mm turrets and munitions to an international customer, a deal that will be executed over a six‑year period. The order includes the UT30MK2, a configurable turret that can operate in both manned and unmanned modes and houses a 30 mm main gun, a 7.62 mm coaxial weapon, and anti‑tank guided missiles.
The win expands Elbit’s order backlog to $25.2 billion as of September 30, 2025, and adds a new revenue stream that is expected to be recognized over the next several years. In the third quarter of 2025, the company reported $1.922 billion in revenue, a double‑digit increase driven by strong demand for its advanced land‑systems portfolio.
"These contracts reflect confidence in both our operational‑proven systems and our ability to develop strategic, future‑oriented capabilities. We take pride in being recognized not only for reliable, fielded solutions, but also for our capacity to innovate and adapt to the evolving challenges of the modern battlefield," said President and CEO Bezhalel (Butzi) Machlis. The CEO added that the contracts demonstrate the customer’s confidence in Elbit’s advanced land‑systems and munitions technologies and highlight the company’s ability to deliver high‑performance, operational solutions to armed forces worldwide.
The UT30MK2’s modular design and open architecture allow rapid conversion between manned and unmanned configurations, positioning the system as a versatile solution for armored personnel carriers in modern conflict zones. The contract underscores Elbit’s successful strategy of securing high‑value deals outside Israel, reinforcing its global diversification and margin‑expansion focus.
Elbit’s management noted that the new contract, combined with its existing backlog, provides strong earnings visibility and supports the company’s long‑term growth trajectory. The deal is a key component of Elbit’s broader narrative of delivering turnkey, high‑margin platforms to a growing international customer base.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.